Pakistan

Pakistan

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
5.63 (4.44 - 7.31) 2015 Modelled WHO
2.1 (2 - 3.30) 2016 Modelled Razavi-Shearer et al, 2018
2.76 (2.73 - 2.79) 2013 Modelled Schweitzer et al, 2015
2.5 2010 Survey/reported Qureshi et al, 2010
2.3 (2.04 - 2.61) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2.52 (2.23 - 2.85) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.55 (2.24 - 2.89) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.71 (2.39 - 3.05) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.86 (2.53 - 3.22) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.83 (2.53 - 3.14) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.77 (2.49 - 3.05) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.69 (2.45 - 2.95) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.62 (2.40 - 2.85) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.57 (2.37 - 2.79) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.56 (2.36 - 2.78) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.58 (2.39 - 2.79) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.62 (2.43 - 2.83) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.67 (2.47 - 2.88) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.7 (2.50 - 2.91) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.73 (2.53 - 2.95) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.8 (2.59 - 3.04) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.89 (2.65 - 3.14) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.97 (2.71 - 3.25) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3.03 (2.76 - 3.32) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3.12 (2.84 - 3.42) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3.25 (2.95 - 3.58) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3.41 (3.08 - 3.76) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.56 (3.19 - 3.92) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.66 (3.29 - 4.05) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.73 (3.33 - 4.16) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.8 (3.36 - 4.26) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.85 (3.38 - 4.35) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3.9 (3.38 - 4.45) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.92 (3.35 - 4.55) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2.52 (2.23 - 2.83) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
2.75 (2.02 - 3.67) 2015 Modelled WHO
0.54 (0.43 - 0.68) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.63 (0.50 - 0.79) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.66 (0.52 - 0.82) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.7 (0.55 - 0.86) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.60 - 0.91) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.63 - 0.96) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.64 - 0.96) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.65 - 0.96) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.66 - 0.96) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.66 - 0.95) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.67 - 0.95) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.67 - 0.95) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.67 - 0.95) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.67 - 0.96) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.68 - 0.96) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.69 - 0.98) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.81 - 1.14) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.26 (1.04 - 1.49) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.61 (1.33 - 1.91) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.93 (1.59 - 2.29) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.12 (1.75 - 2.52) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.21 (1.83 - 2.63) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.3 (1.89 - 2.74) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.37 (1.96 - 2.84) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.43 (1.99 - 2.92) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.47 (2.01 - 2.99) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.5 (2.02 - 3.04) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.53 (2.03 - 3.09) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.55 (2.04 - 3.14) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.57 (2.04 - 3.20) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.57 (2.01 - 3.26) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.79 - 1.04) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
3,962,000 (3,906,000 - 6,364,000) 2016 Modelled Razavi-Shearer et al, 2018
5,161,400 (4,570,900 - 5,838,200) 2019 Modelled IHME, GBD 2019 (accessed 2020)
5,363,750 (4,755,000 - 6,038,170) 2019 Modelled IHME, GBD 2019 (accessed 2022)
5,263,860 (4,668,650 - 5,946,140) 2018 Modelled IHME, GBD 2019 (accessed 2022)
5,212,530 (4,575,290 - 5,916,670) 2017 Modelled IHME, GBD 2019 (accessed 2022)
5,420,940 (4,787,850 - 6,093,410) 2016 Modelled IHME, GBD 2019 (accessed 2022)
5,579,400 (4,936,260 - 6,265,730) 2015 Modelled IHME, GBD 2019 (accessed 2022)
5,408,230 (4,829,360 - 6,008,290) 2014 Modelled IHME, GBD 2019 (accessed 2022)
5,173,940 (4,665,950 - 5,690,620) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4,919,100 (4,483,600 - 5,399,620) 2012 Modelled IHME, GBD 2019 (accessed 2022)
4,680,860 (4,305,390 - 5,107,760) 2011 Modelled IHME, GBD 2019 (accessed 2022)
4,492,900 (4,134,790 - 4,888,110) 2010 Modelled IHME, GBD 2019 (accessed 2022)
4,377,400 (4,043,160 - 4,744,960) 2009 Modelled IHME, GBD 2019 (accessed 2022)
4,316,620 (4,000,570 - 4,662,700) 2008 Modelled IHME, GBD 2019 (accessed 2022)
4,282,450 (3,974,150 - 4,616,560) 2007 Modelled IHME, GBD 2019 (accessed 2022)
4,249,100 (3,950,680 - 4,577,180) 2006 Modelled IHME, GBD 2019 (accessed 2022)
4,194,770 (3,892,800 - 4,515,980) 2005 Modelled IHME, GBD 2019 (accessed 2022)
4,155,880 (3,848,980 - 4,485,980) 2004 Modelled IHME, GBD 2019 (accessed 2022)
4,162,690 (3,841,520 - 4,509,340) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4,187,640 (3,850,620 - 4,552,820) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4,204,290 (3,839,350 - 4,588,300) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4,188,740 (3,814,630 - 4,590,090) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4,201,480 (3,820,710 - 4,609,920) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4,284,270 (3,892,510 - 4,701,020) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4,390,970 (3,972,380 - 4,830,490) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4,479,010 (4,028,740 - 4,935,800) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4,509,680 (4,034,130 - 4,984,660) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4,496,600 (3,997,820 - 5,002,380) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4,474,850 (3,947,330 - 5,009,740) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4,440,780 (3,893,790 - 5,005,930) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4,391,310 (3,802,880 - 5,021,410) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4,323,500 (3,696,180 - 5,002,780) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.23 (5.30 - 9.67) 2019 Modelled IHME, GBD 2019 (accessed 2020)
8.56 (5.41 - 12.17) 1990 Modelled IHME, GBD 2019 (accessed 2022)
8.57 (5.48 - 12.12) 1991 Modelled IHME, GBD 2019 (accessed 2022)
8.59 (5.59 - 11.83) 1992 Modelled IHME, GBD 2019 (accessed 2022)
8.57 (5.64 - 11.61) 1993 Modelled IHME, GBD 2019 (accessed 2022)
8.6 (5.87 - 11.56) 1994 Modelled IHME, GBD 2019 (accessed 2022)
8.69 (6.06 - 11.54) 1995 Modelled IHME, GBD 2019 (accessed 2022)
8.67 (6.06 - 11.22) 1996 Modelled IHME, GBD 2019 (accessed 2022)
8.6 (6.19 - 11.04) 1997 Modelled IHME, GBD 2019 (accessed 2022)
8.46 (6.19 - 10.80) 1998 Modelled IHME, GBD 2019 (accessed 2022)
8.39 (6.17 - 10.68) 1999 Modelled IHME, GBD 2019 (accessed 2022)
8.27 (6.17 - 10.45) 2002 Modelled IHME, GBD 2019 (accessed 2022)
8.4 (6.13 - 10.83) 2000 Modelled IHME, GBD 2019 (accessed 2022)
8.37 (6.22 - 10.56) 2001 Modelled IHME, GBD 2019 (accessed 2022)
8.13 (6.11 - 10.20) 2003 Modelled IHME, GBD 2019 (accessed 2022)
7.89 (6.04 - 9.93) 2005 Modelled IHME, GBD 2019 (accessed 2022)
8 (6.05 - 10.01) 2004 Modelled IHME, GBD 2019 (accessed 2022)
7.79 (5.83 - 9.85) 2006 Modelled IHME, GBD 2019 (accessed 2022)
7.7 (5.73 - 9.85) 2007 Modelled IHME, GBD 2019 (accessed 2022)
7.67 (5.75 - 9.81) 2008 Modelled IHME, GBD 2019 (accessed 2022)
7.63 (5.58 - 9.82) 2009 Modelled IHME, GBD 2019 (accessed 2022)
7.57 (5.54 - 9.79) 2010 Modelled IHME, GBD 2019 (accessed 2022)
7.48 (5.35 - 9.72) 2011 Modelled IHME, GBD 2019 (accessed 2022)
7.4 (5.50 - 9.68) 2012 Modelled IHME, GBD 2019 (accessed 2022)
7.38 (5.43 - 9.64) 2013 Modelled IHME, GBD 2019 (accessed 2022)
7.33 (5.45 - 9.62) 2014 Modelled IHME, GBD 2019 (accessed 2022)
7.25 (5.28 - 9.58) 2016 Modelled IHME, GBD 2019 (accessed 2022)
7.26 (5.25 - 9.54) 2015 Modelled IHME, GBD 2019 (accessed 2022)
7.3 (5.27 - 9.76) 2017 Modelled IHME, GBD 2019 (accessed 2022)
7.26 (5.25 - 9.75) 2018 Modelled IHME, GBD 2019 (accessed 2022)
7.23 (5.30 - 9.67) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
15,531 2016 Modelled WHO
9,657 (6,100 - 13,729) 1990 Modelled IHME, GBD 2019 (accessed 2022)
9,894 (6,329 - 13,986) 1991 Modelled IHME, GBD 2019 (accessed 2022)
10,135 (6,599 - 13,963) 1992 Modelled IHME, GBD 2019 (accessed 2022)
10,342 (6,811 - 14,010) 1993 Modelled IHME, GBD 2019 (accessed 2022)
10,973 (7,655 - 14,565) 1995 Modelled IHME, GBD 2019 (accessed 2022)
11,202 (7,830 - 14,491) 1996 Modelled IHME, GBD 2019 (accessed 2022)
10,612 (7,238 - 14,262) 1994 Modelled IHME, GBD 2019 (accessed 2022)
11,372 (8,182 - 14,594) 1997 Modelled IHME, GBD 2019 (accessed 2022)
11,459 (8,383 - 14,627) 1998 Modelled IHME, GBD 2019 (accessed 2022)
11,638 (8,562 - 14,813) 1999 Modelled IHME, GBD 2019 (accessed 2022)
11,948 (8,715 - 15,402) 2000 Modelled IHME, GBD 2019 (accessed 2022)
12,370 (9,232 - 15,624) 2002 Modelled IHME, GBD 2019 (accessed 2022)
12,201 (9,063 - 15,388) 2001 Modelled IHME, GBD 2019 (accessed 2022)
12,583 (9,524 - 15,756) 2004 Modelled IHME, GBD 2019 (accessed 2022)
12,465 (9,378 - 15,639) 2003 Modelled IHME, GBD 2019 (accessed 2022)
12,732 (9,747 - 16,025) 2005 Modelled IHME, GBD 2019 (accessed 2022)
12,898 (9,656 - 16,298) 2006 Modelled IHME, GBD 2019 (accessed 2022)
13,074 (9,734 - 16,719) 2007 Modelled IHME, GBD 2019 (accessed 2022)
13,622 (9,966 - 17,526) 2009 Modelled IHME, GBD 2019 (accessed 2022)
13,359 (10,008 - 17,093) 2008 Modelled IHME, GBD 2019 (accessed 2022)
13,860 (10,135 - 17,916) 2010 Modelled IHME, GBD 2019 (accessed 2022)
14,023 (10,034 - 18,218) 2011 Modelled IHME, GBD 2019 (accessed 2022)
14,209 (10,556 - 18,591) 2012 Modelled IHME, GBD 2019 (accessed 2022)
14,515 (10,671 - 18,946) 2013 Modelled IHME, GBD 2019 (accessed 2022)
15,249 (11,104 - 20,149) 2016 Modelled IHME, GBD 2019 (accessed 2022)
14,927 (10,797 - 19,620) 2015 Modelled IHME, GBD 2019 (accessed 2022)
14,749 (10,970 - 19,338) 2014 Modelled IHME, GBD 2019 (accessed 2022)
15,686 (11,324 - 20,956) 2017 Modelled IHME, GBD 2019 (accessed 2022)
15,916 (11,508 - 21,399) 2018 Modelled IHME, GBD 2019 (accessed 2022)
16,208 (11,878 - 21,656) 2019 Modelled IHME, GBD 2019 (accessed 2022)
16,208 (11,878 - 21,656) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
3 (2 - 4) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3 (3 - 4) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3 (3 - 4) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3 (3 - 4) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3 (3 - 4) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3 (3 - 4) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3 (3 - 4) 2005 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2007 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 4) 2006 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2009 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2008 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2011 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2010 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2012 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2015 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2014 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2016 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2017 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2019 Modelled IHME, GBD 2019 (accessed 2022)
4 (4 - 6) 2018 Modelled IHME, GBD 2019 (accessed 2022)
18 (15 - 21) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
75 2019 Survey/reported WHO/UNICEF
77 2020 Survey/reported WHO/UNICEF
83 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
18 (16 - 21) 2015 Survey/reported Larney et al, 2017
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2015 Survey/reported NACP, 2015.
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Pregnant women
HepB birth dose policy
Yes
Eligible for HBV generic medicines
Year of birth dose introduction
2016
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
3.8 (2.80 - 3.90) 2015 Modelled Blach et al, 2017
5.8 (1.40 - 8.70) 2014 Modelled Gower et al, 2014
1.78 (1.42 - 2.21) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.78 (1.43 - 2.20) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.79 (1.43 - 2.21) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.02 (1.62 - 2.49) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.3 (1.85 - 2.84) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.41 (1.94 - 2.98) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.5 (2.02 - 3.09) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.57 (2.08 - 3.18) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.62 (2.11 - 3.23) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.63 (2.12 - 3.26) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.63 (2.12 - 3.24) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.61 (2.11 - 3.22) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.6 (2.09 - 3.20) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.58 (2.09 - 3.19) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.57 (2.07 - 3.16) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.5 (2.02 - 3.09) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.37 (1.91 - 2.93) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.22 (1.79 - 2.75) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.1 (1.69 - 2.59) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.05 (1.65 - 2.53) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.06 (1.66 - 2.54) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.09 (1.68 - 2.56) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.12 (1.71 - 2.61) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.16 (1.73 - 2.65) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.18 (1.75 - 2.68) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.18 (1.75 - 2.68) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.17 (1.75 - 2.68) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.16 (1.73 - 2.67) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.13 (1.71 - 2.66) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.1 (1.68 - 2.63) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.68 (1.34 - 2.09) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
4.09 (3.06 - 4.27) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
6.7 (1.60 - 10) 2014 Modelled Gower et al, 2014
4.8 2010 Survey/reported Qureshi et al, 2010
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
36.5 (0 - 79.10) 2013 Modelled Degenhardt L et al, 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
7,172,000 (5,363,000 - 7,487,000) 2015 Modelled Blach et al, 2017
2,315,320 (1,854,900 - 2,899,710) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2,403,620 (1,929,160 - 2,999,070) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2,484,960 (1,991,470 - 3,084,730) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2,558,500 (2,057,480 - 3,164,100) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2,623,790 (2,106,000 - 3,228,000) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2,680,230 (2,143,650 - 3,301,320) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2,717,980 (2,182,430 - 3,346,810) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2,736,500 (2,201,320 - 3,368,090) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2,750,040 (2,215,590 - 3,380,780) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2,774,480 (2,232,440 - 3,420,190) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2,826,620 (2,279,400 - 3,490,010) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2,970,320 (2,394,170 - 3,664,170) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3,221,090 (2,594,740 - 3,958,980) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3,519,890 (2,837,810 - 4,338,260) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3,801,680 (3,069,870 - 4,688,320) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3,993,360 (3,223,580 - 4,901,160) 2005 Modelled IHME, GBD 2019 (accessed 2022)
4,115,700 (3,324,020 - 5,060,570) 2006 Modelled IHME, GBD 2019 (accessed 2022)
4,240,740 (3,422,690 - 5,224,430) 2007 Modelled IHME, GBD 2019 (accessed 2022)
4,365,460 (3,516,140 - 5,378,220) 2008 Modelled IHME, GBD 2019 (accessed 2022)
4,487,790 (3,612,400 - 5,550,220) 2009 Modelled IHME, GBD 2019 (accessed 2022)
4,605,460 (3,700,900 - 5,700,080) 2010 Modelled IHME, GBD 2019 (accessed 2022)
4,687,700 (3,773,350 - 5,796,990) 2011 Modelled IHME, GBD 2019 (accessed 2022)
4,709,350 (3,796,270 - 5,814,670) 2012 Modelled IHME, GBD 2019 (accessed 2022)
4,677,050 (3,775,130 - 5,778,830) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4,598,950 (3,717,030 - 5,692,650) 2014 Modelled IHME, GBD 2019 (accessed 2022)
4,484,290 (3,626,480 - 5,557,990) 2015 Modelled IHME, GBD 2019 (accessed 2022)
4,028,680 (3,237,380 - 4,989,090) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3,653,510 (2,923,220 - 4,526,480) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3,714,410 (2,968,620 - 4,593,600) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3,801,920 (3,024,380 - 4,710,050) 2019 Modelled IHME, GBD 2019 (accessed 2022)
3,774,440 (2,999,760 - 4,679,890) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
2,219,000 (1,659,000 - 2,316,000) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
7.87 (5.69 - 11) 2019 Modelled IHME, GBD 2019 (accessed 2020)
10.08 (6.43 - 15.21) 1990 Modelled IHME, GBD 2019 (accessed 2022)
10.02 (6.50 - 14.94) 1991 Modelled IHME, GBD 2019 (accessed 2022)
9.92 (6.73 - 14.42) 1993 Modelled IHME, GBD 2019 (accessed 2022)
9.99 (6.61 - 14.73) 1992 Modelled IHME, GBD 2019 (accessed 2022)
9.96 (7.09 - 13.93) 1995 Modelled IHME, GBD 2019 (accessed 2022)
9.91 (6.88 - 14.08) 1994 Modelled IHME, GBD 2019 (accessed 2022)
9.89 (7.14 - 13.47) 1996 Modelled IHME, GBD 2019 (accessed 2022)
9.78 (7.28 - 13.06) 1997 Modelled IHME, GBD 2019 (accessed 2022)
9.6 (7.17 - 12.91) 1998 Modelled IHME, GBD 2019 (accessed 2022)
9.48 (7.18 - 12.53) 1999 Modelled IHME, GBD 2019 (accessed 2022)
9.45 (7.22 - 12.36) 2000 Modelled IHME, GBD 2019 (accessed 2022)
9.27 (7.18 - 11.99) 2002 Modelled IHME, GBD 2019 (accessed 2022)
9.38 (7.23 - 12.11) 2001 Modelled IHME, GBD 2019 (accessed 2022)
9.11 (7.08 - 11.56) 2003 Modelled IHME, GBD 2019 (accessed 2022)
8.96 (7 - 11.61) 2004 Modelled IHME, GBD 2019 (accessed 2022)
8.82 (6.81 - 11.27) 2005 Modelled IHME, GBD 2019 (accessed 2022)
8.7 (6.68 - 11.15) 2006 Modelled IHME, GBD 2019 (accessed 2022)
8.53 (6.63 - 11.24) 2008 Modelled IHME, GBD 2019 (accessed 2022)
8.59 (6.60 - 11.07) 2007 Modelled IHME, GBD 2019 (accessed 2022)
8.4 (6.24 - 11.02) 2010 Modelled IHME, GBD 2019 (accessed 2022)
8.47 (6.35 - 11.08) 2009 Modelled IHME, GBD 2019 (accessed 2022)
8.31 (6.19 - 10.92) 2011 Modelled IHME, GBD 2019 (accessed 2022)
8.25 (6.07 - 11.03) 2012 Modelled IHME, GBD 2019 (accessed 2022)
8.27 (5.99 - 11.13) 2013 Modelled IHME, GBD 2019 (accessed 2022)
8.24 (6.09 - 11.11) 2014 Modelled IHME, GBD 2019 (accessed 2022)
8.16 (5.96 - 11.03) 2015 Modelled IHME, GBD 2019 (accessed 2022)
8.13 (6 - 10.89) 2016 Modelled IHME, GBD 2019 (accessed 2022)
8.15 (5.94 - 10.98) 2017 Modelled IHME, GBD 2019 (accessed 2022)
8.03 (5.78 - 10.91) 2018 Modelled IHME, GBD 2019 (accessed 2022)
7.87 (5.69 - 10.96) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
12,122 2016 Modelled WHO
17,644 (12,752 - 24,554) 2019 Modelled IHME, GBD 2019 (accessed 2022)
17,644 (12,752 - 24,554) 2019 Modelled IHME, GBD 2019 (accessed 2020)
17,606 (12,684 - 23,927) 2018 Modelled IHME, GBD 2019 (accessed 2022)
17,502 (12,769 - 23,584) 2017 Modelled IHME, GBD 2019 (accessed 2022)
17,094 (12,617 - 22,890) 2016 Modelled IHME, GBD 2019 (accessed 2022)
16,793 (12,256 - 22,683) 2015 Modelled IHME, GBD 2019 (accessed 2022)
16,569 (12,252 - 22,347) 2014 Modelled IHME, GBD 2019 (accessed 2022)
16,252 (11,766 - 21,883) 2013 Modelled IHME, GBD 2019 (accessed 2022)
15,845 (11,655 - 21,185) 2012 Modelled IHME, GBD 2019 (accessed 2022)
15,579 (11,600 - 20,467) 2011 Modelled IHME, GBD 2019 (accessed 2022)
15,371 (11,414 - 20,171) 2010 Modelled IHME, GBD 2019 (accessed 2022)
15,122 (11,335 - 19,790) 2009 Modelled IHME, GBD 2019 (accessed 2022)
14,862 (11,539 - 19,580) 2008 Modelled IHME, GBD 2019 (accessed 2022)
14,579 (11,208 - 18,799) 2007 Modelled IHME, GBD 2019 (accessed 2022)
14,395 (11,063 - 18,452) 2006 Modelled IHME, GBD 2019 (accessed 2022)
14,232 (10,984 - 18,192) 2005 Modelled IHME, GBD 2019 (accessed 2022)
14,098 (11,009 - 18,265) 2004 Modelled IHME, GBD 2019 (accessed 2022)
13,975 (10,856 - 17,735) 2003 Modelled IHME, GBD 2019 (accessed 2022)
13,861 (10,739 - 17,926) 2002 Modelled IHME, GBD 2019 (accessed 2022)
13,671 (10,545 - 17,661) 2001 Modelled IHME, GBD 2019 (accessed 2022)
13,440 (10,269 - 17,568) 2000 Modelled IHME, GBD 2019 (accessed 2022)
13,148 (9,955 - 17,386) 1999 Modelled IHME, GBD 2019 (accessed 2022)
12,993 (9,708 - 17,473) 1998 Modelled IHME, GBD 2019 (accessed 2022)
12,925 (9,625 - 17,267) 1997 Modelled IHME, GBD 2019 (accessed 2022)
12,775 (9,227 - 17,400) 1996 Modelled IHME, GBD 2019 (accessed 2022)
12,572 (8,953 - 17,585) 1995 Modelled IHME, GBD 2019 (accessed 2022)
12,227 (8,487 - 17,376) 1994 Modelled IHME, GBD 2019 (accessed 2022)
11,973 (8,126 - 17,396) 1993 Modelled IHME, GBD 2019 (accessed 2022)
11,786 (7,806 - 17,382) 1992 Modelled IHME, GBD 2019 (accessed 2022)
11,566 (7,503 - 17,243) 1991 Modelled IHME, GBD 2019 (accessed 2022)
11,379 (7,256 - 17,165) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
9 (6 - 13) 1990 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 1991 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 1992 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 1993 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 1994 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 1995 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 1996 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 1997 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 12) 1999 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 1998 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 12) 2000 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 12) 2001 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 12) 2003 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 13) 2004 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 12) 2002 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 12) 2005 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 13) 2006 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 13) 2007 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 13) 2008 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 13) 2009 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 13) 2010 Modelled IHME, GBD 2019 (accessed 2022)
11 (9 - 13) 2011 Modelled IHME, GBD 2019 (accessed 2022)
11 (9 - 14) 2012 Modelled IHME, GBD 2019 (accessed 2022)
11 (9 - 14) 2013 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 14) 2014 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 2016 Modelled IHME, GBD 2019 (accessed 2022)
12 (10 - 15) 2017 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 14) 2015 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 16) 2018 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 16) 2019 Modelled IHME, GBD 2019 (accessed 2022)
50 (44 - 54) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of persons treated for HCV

National
Download
Value Year Type Source
6,500 2015 Survey/reported WHO, 2018
161,000 2016 Survey/reported WHO, 2018
Showing out of
Show more
Technical notes

Cumulative number of persons treated for HCV

National
Download
Value Year Type Source
200,000 2018 Survey/reported WHO, 2021

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
18 (16 - 21) 2015 Survey/reported Larney et al, 2017
Technical notes

Number of 28-pill count bottles exported from Indian manufacturers (SOF-based regimens)

National
Download
Value Year Type Source
73,386 2016 Survey/reported CHAI HCV Market Report
100,002 2017 Survey/reported CHAI HCV Market Report
104,504 2018 Survey/reported CHAI HCV Market Report
68,661 2019 Survey/reported CHAI HCV Market Report
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2015 Survey/reported NACP, 2015.

Price of HCV cure (Lowest average FOB price for 3 months of pangenotypic regimens)

National
Download
Value (US $) Year Type Source
231 2016 Survey/reported CHAI HCV Market Report
84 2017 Survey/reported CHAI HCV Market Report
60 2018 Survey/reported CHAI HCV Market Report
75 2019 Survey/reported CHAI HCV Market Report
Showing out of
Show more
Technical notes

Price of HCV cure (Average price in public sector for 3 months of DAAs)

National
Download
Value (US $) Year Type Source
90.75 2019 Survey/reported WHO, 2021

Price of HCV cure (Cheapest price in public sector for 3 months of DAAs)

National
Download
Value (US $) Year Type Source
21 2019 Survey/reported WHO, 2021
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Pregnant women
HepB birth dose policy
Yes
Eligible for HBV generic medicines
Year of birth dose introduction
2016
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Overview

Resources